Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Sustained Therapeutics Advancing Clinical Trial for Novel Drug Delivery Platform
A Vancouver-based therapeutics company, Sustained Therapeutics, has received regulatory approval to begin the second Phase […]
Turbine’s AI-powered Cancer Cell Simulations Will Be Used to Identify Novel Disease Positioning Strategies in Cancer Research UK’s Latest Biotech Partnership
Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder […]
B dot Medical to Install Its First Practical Ultra-compact Proton Therapy System at Hospital in Tokyo
B dot Medical has signed a memorandum of understanding with Edogawa Hospital in Japan for […]
Zhongchao Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma
Zhongchao, a platform-based internet technology company offering services to patients with oncology and other major […]
ENHERTU® Type II Variation Application Validated by EMA for the Treatment of HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Daiichi Sankyo has announced that the European Medicines Agency (EMA) has validated the Type II […]
A Record Year For People Receiving NHS Cancer Treatment
Thousands more people started vital treatment for cancer over the last year compared to before […]
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines […]
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell […]
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Biocytogen Pharmaceuticals (Beijing), a clinical-stage biotechnology company with a focus on the antibody discovery and […]
U.S. FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors
Datar Cancer Genetics has announced that the US Food and Drug Administration (FDA) has granted […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more